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Trinucleotide repeat disorders are a heterogeneous group of diseases caused by the expansion, beyond a
pathogenic threshold, of unstable DNA tracts in different genes. Sequence interruptions in the repeats
have been described in the majority of these disorders and may inﬂuence disease phenotype and her-
itability. Spinal bulbar muscular atrophy (SBMA) is a motor neuron disease caused by a CAG trinucleotide
expansion in the androgen receptor (AR) gene. Diagnostic testing and previous research have relied on
fragment analysis polymerase chain reaction to determine the AR CAG repeat size, and have therefore not
been able to assess the presence of interruptions. We here report a sequencing study of the AR CAG
repeat in a cohort of SBMA patients and control subjects in the United Kingdom. We found no repeat
interruptions to be present, and we describe differences between sequencing and traditional sizing
methods.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction Interruptions have been shown to play a role in determiningSpinal bulbar muscular atrophy (SBMA), also known as Ken-
nedy’s disease, is a slowly progressive, adult-onset, motor neuron
disease, inherited in an X-linked recessive manner and caused by a
CAG repeat expansion in the ﬁrst exon of the androgen receptor
gene (AR) (La Spada et al., 1991). Although normal individuals carry
9 to 36 CAG repeats, SBMA patients carry 38 to 62 repeats (La Spada
et al., 1991). SBMA is part of a wider group of neurological diseases
inwhich the causative genetic defect is a coding CAG expansion and
for which the pathogenic threshold is approximately 35 to 40 re-
peats (Table 1) (Atsuta et al., 2006; Orr and Zoghbi, 2007). Inter-
estingly, although most frequently the CAG expansions are pure
runs of CAGs, sequence interruptions have been documented in the
majority of these disease genes (Table 1).er the terms of the Creative
cense, which permits non-
any medium, provided the
generative Diseas, UCL Insti-
K. Tel.: þ44 (0)2034484448;
Published by Elsevier Inc. All righthe clinical phenotype and the disease heritability, and therefore
carry potentially important information for genetic testing and
counseling (Chong et al., 1995; Matsuyama et al., 1999; Yu et al.,
2011). Pulic genomic databases report rare sequence variations
(rs62636527, rs62636528, rs62636529) occurring with low fre-
quency (0.013e0.043) in the AR CAG repeat, but SBMA diagnostic
testing and previous studies have mostly used fragment sizing
analysis to assess the presence and size of CAG repeats (Atsuta et al.,
2006; La Spada et al., 1991), and have not been able to systemati-
cally address whether there are interruptions in SBMA expansions,
thus warranting direct target sequence analysis.
2. Methods
Details of the patient cohorts, fragment sizing, and sequencing
are given in the Supplementary text. The studywas approved by the
local ethical committee.
3. Results
To investigate the presence of interruptions in the AR CAG
repeat, we sequenced the AR CAG repeat in a population of 40 SBMA
patients and 93 control subjects in the United Kingdom. Overall,
SBMA samples showed a median of 45 repeats (range, 40e53ts reserved.
Table 1
Summary of CAG characteristics in diseases caused by CAG coding expansions
Disease Gene No. of CAG repeats Presence of
interruptions in
CAG repeat
sequence
Reference
Normal
allele
Intermediate
allele
Reduced penetrance
allele
Fully penetrant
allele
DRPLA ATN1 6e35 36e47 48e93 No Koide et al., 1994
SCA1 ATXN1 6e38 36e38 39e91 Yes Orr et al., 1993
SCA2 ATXN2 14e31 32e270 Yes Pulst et al., 1996
SCA3 ATXN3 12e44 45e51 52e86 Yes Kawaguchi et al., 1994
SCA17 TBP 25e40 41e48 49e66 Yes Koide et al., 1999
HD HTT 26 27e35 36e39 40 Yes Huntington’s Disease Collaborative Research Group, 1993
SBMA AR 9e36 37 38e62 No La Spada et al., 1991; present work
Key: SBMA, spinal bulbar muscular atrophy.
P. Fratta et al. / Neurobiology of Aging 35 (2014) 443.e1e443.e3443.e2repeats; Supplementary Fig. 1), which is comparable to the results
reported in previous U.S. and Japanese series (Atsuta et al., 2006; La
Spada et al., 1991). The quality of our direct sequencing of the CAG
expansion allowed us to address the presence of interruptions by
visual inspection in both forward and reverse sequences of the
amplicon (Supplementary Fig. 2). We did not ﬁnd interruptions in
any of our SBMA case patients or control subjects (Table 1).
Interestingly, when comparing sizing obtained by sequencing
to the fragment analysis used diagnostically, we observed a
constant difference of 3 to 4 repeats, with estimation from
fragment analysis being smaller. This was not dependent on the
allele size, and was constant among pathological alleles and
controls.4. Discussion
Diagnostic testing and previous large-scale studies have relied
on polymerase chain reaction fragment analysis for sizing the CAG
repeat in AR, and have therefore not been able to address the
presence of sequence interruptions in a large number of samples
(Atsuta et al., 2006; La Spada et al., 1991). This is an important
issue, because interruptions have been shown to be present in the
majority of CAG expansion diseases and to play a role in clinical
features of the disease, such as age of onset and presentation.
In the case of ataxin 2 (ATXN2), the combination of presence of
interruptions and repeat size determines very distinct clinical
presentations that encompass SCA2, L-DOPAeresponsive parkin-
sonism, and amyotrophic lateral sclerosis (Matsuyama et al., 1999;
Yu et al., 2011). Interruptions have also been shown to inﬂuence
the capability of the repeat to expand in the germ line, therefore
carrying potential implications for genetic counseling (Chung
et al., 1993).
Importantly, our results show that interruptions are not
frequent in the AR CAG repeat and are therefore not likely to play a
role in disease, making SBMA an exception among coding CAG
expansion diseases.
Our results also show that fragment analysis, used routinely for
the diagnostic testing of the SBMA and other CAG expansion dis-
eases, underestimates the CAG expansion. This discrepancy is pre-
sent also when analysing CAG expansions from other genes (Menon
et al., 2013). In diagnostic laboratories, this bias is corrected for by
calibrating the fragment analysis with amplicons of known sizes.
Our results indicate that direct sequencing of the AR CAG repeat
polymerase chain reaction amplicon in males is a reliable method
for sizing evaluation, and therefore we suggest that this may be
useful when analyzing size lengths of the CAG repeat near the dis-
ease threshold of 38 repeats. This possibility is unique to SBMA
testing in males and differs from all other triplet expansion diseases
in which the presence of sequence variability and the effect ofhaving 2 alleles, makes direct polymerase chain reaction sequencing
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